deucravacitinib,apremilast,adalimumab,nivolumab,relatlimab,mavacamten,brepocitinib
bms,amgen,abbvie,pfizer
['psoriasis', 'bms', '$bmy', 'bmsnews']
. approval sets up $bmy's sotyktu as oral therapy of choice in psoriasis. via 's 
Executive Editor, @BioCentury. Jersey boy happily ensconced in Cali. Dad. Failed poet. Devoted Iggles fan. Cats. @Princeton, @SAISHopkins alum. Opinions? Mine.